pteridines has been researched along with Hematologic Neoplasms in 1 studies
Hematologic Neoplasms: Neoplasms located in the blood and blood-forming tissue (the bone marrow and lymphatic tissue). The commonest forms are the various types of LEUKEMIA, of LYMPHOMA, and of the progressive, life-threatening forms of the MYELODYSPLASTIC SYNDROMES.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Volasertib is a Plk inhibitor under evaluation combined with low-dose cytarabine in older patients with acute myeloid leukemia (AML) ineligible for intensive induction therapy." | 2.53 | Polo-like kinase inhibitors in hematologic malignancies. ( Griffiths, EA; Talati, C; Wang, ES; Wetzler, M, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Talati, C | 1 |
| Griffiths, EA | 1 |
| Wetzler, M | 1 |
| Wang, ES | 1 |
1 review available for pteridines and Hematologic Neoplasms
| Article | Year |
|---|---|
Polo-like kinase inhibitors in hematologic malignancies.
Topics: 4-Aminobenzoic Acid; Azepines; Benzazepines; Cell Cycle Proteins; Clinical Trials, Phase III as Topi | 2016 |